Applied DNA Sciences Future Growth
Future criteria checks 0/6
Applied DNA Sciences's revenue and earnings are forecast to decline at 3.7% and 29.3% per annum respectively while EPS is expected to grow by 2.9% per annum.
Key information
-29.3%
Earnings growth rate
2.9%
EPS growth rate
Life Sciences earnings growth | 17.4% |
Revenue growth rate | -3.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Feb 2024 |
Recent future growth updates
Recent updates
The Market Doesn't Like What It Sees From Applied DNA Sciences, Inc.'s (NASDAQ:APDN) Revenues Yet As Shares Tumble 26%
Dec 20Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?
Jan 01Applied DNA climbs 51% after winning large purchase order
Oct 10Applied DNA stock rises 12% on launching monkeypox testing service in New York
Sep 06Applied DNA adds 17% as company seeks approval for monkeypox test in New York
Aug 19Upgrade: Analysts Just Made A Notable Increase To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts
Aug 17Applied DNA Sciences gains as it secures ~$3.6M proceeds from warrant exercise
Aug 09Applied DNA stock soars 73% on starting validation of PCR-based monkeypox test
Aug 02Applied DNA announces positive data from veterinary vaccine trial to treat COVID-19
Jul 25News Flash: Analysts Just Made A Notable Upgrade To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts
May 18Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Deliver On Growth Plans?
Sep 17Applied DNA's LinearDNA COVID-19 vaccine booster yields 5-fold increase in neutralizing antibody in felines
May 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2025 | 8 | -13 | N/A | N/A | 2 |
9/30/2024 | 5 | -13 | N/A | N/A | 2 |
12/31/2023 | 9 | -7 | -9 | -8 | N/A |
9/30/2023 | 13 | -10 | -7 | -6 | N/A |
6/30/2023 | 16 | -7 | -7 | -7 | N/A |
3/31/2023 | 18 | -5 | -8 | -7 | N/A |
12/31/2022 | 19 | -7 | -8 | -8 | N/A |
9/30/2022 | 18 | -8 | -9 | -9 | N/A |
6/30/2022 | 18 | -12 | -12 | -10 | N/A |
3/31/2022 | 15 | -15 | -12 | -10 | N/A |
12/31/2021 | 12 | -14 | -15 | -13 | N/A |
9/30/2021 | 9 | -14 | -16 | -13 | N/A |
6/30/2021 | 6 | -14 | -14 | -12 | N/A |
3/31/2021 | 5 | -14 | -16 | -13 | N/A |
12/31/2020 | 3 | -15 | -14 | -13 | N/A |
9/30/2020 | 2 | -13 | -12 | -11 | N/A |
6/30/2020 | 3 | -10 | -10 | -10 | N/A |
3/31/2020 | 5 | -9 | -8 | -8 | N/A |
12/31/2019 | 5 | -8 | -8 | -8 | N/A |
9/30/2019 | 5 | -9 | -7 | -7 | N/A |
6/30/2019 | 5 | -11 | -8 | -8 | N/A |
3/31/2019 | 4 | -12 | -8 | -7 | N/A |
12/31/2018 | 4 | -12 | -6 | -6 | N/A |
9/30/2018 | 4 | -12 | -7 | -7 | N/A |
6/30/2018 | 4 | -11 | -6 | -5 | N/A |
3/31/2018 | 5 | -11 | -6 | -6 | N/A |
12/31/2017 | 4 | -12 | -8 | -8 | N/A |
9/30/2017 | 5 | -13 | N/A | -7 | N/A |
6/30/2017 | 5 | -12 | N/A | -9 | N/A |
3/31/2017 | 4 | -13 | N/A | -9 | N/A |
12/31/2016 | 4 | -13 | N/A | -9 | N/A |
9/30/2016 | 4 | -12 | N/A | -10 | N/A |
6/30/2016 | 7 | -10 | N/A | -9 | N/A |
3/31/2016 | 8 | -9 | N/A | -8 | N/A |
12/31/2015 | 9 | -7 | N/A | -7 | N/A |
9/30/2015 | 9 | -12 | N/A | -7 | N/A |
6/30/2015 | 6 | -13 | N/A | -7 | N/A |
3/31/2015 | 4 | -14 | N/A | -8 | N/A |
12/31/2014 | 3 | -15 | N/A | -9 | N/A |
9/30/2014 | 3 | -13 | N/A | -9 | N/A |
6/30/2014 | 3 | -15 | N/A | -8 | N/A |
3/31/2014 | 3 | -15 | N/A | -8 | N/A |
12/31/2013 | 2 | -15 | N/A | -8 | N/A |
9/30/2013 | 2 | -18 | N/A | -8 | N/A |
6/30/2013 | 2 | -16 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APDN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: APDN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: APDN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: APDN's revenue is expected to decline over the next 3 years (-3.7% per year).
High Growth Revenue: APDN's revenue is forecast to decline over the next 3 years (-3.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if APDN's Return on Equity is forecast to be high in 3 years time